Cargando…
Immunotherapy for Management of Thymic Epithelial Tumors: A Double-Edged Sword
SIMPLE SUMMARY: Immunotherapy has a rapidly expanding role for the treatment of several cancers due to durable clinical activity and favorable tolerability. However, the unique biology of thymic epithelial tumors (TETs) increases the risk of immune-mediated toxicity. In this paper we review the biol...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105984/ https://www.ncbi.nlm.nih.gov/pubmed/35565190 http://dx.doi.org/10.3390/cancers14092060 |